Zobrazeno 1 - 10
of 14
pro vyhledávání: '"C. D. Blanke"'
Autor:
Andrea J MacNeill, T. Hamilton, Kaylie-Anne Willemsma, C. McGahan, K. Devries, Christine E. Simmons, A. Deruchie Tan, C. D. Blanke, Huaqi Li, Amirrtha Srikanthan
Publikováno v:
Current Oncology
Volume 27
Issue 3
Pages 5869-282
Curr Oncol
Volume 27
Issue 3
Pages 5869-282
Curr Oncol
The real-world impact of tyrosine kinase inhibitors (tkis) in clinical practice for gastrointestinal stromal tumour (gist) has not been extensively reported. We sought to assess how outcomes have changed over the eras and to evaluate the effect of ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d8a3ff94feb75bd89f1652184ef55c8
Autor:
Kimberly Schaff, Hagen F. Kennecke, Caroline Speers, Winson Y. Cheung, Leo Chen, C. D. Blanke
Publikováno v:
Current Oncology
Volume 20
Issue 6
Pages 1600-332
Volume 20
Issue 6
Pages 1600-332
The survival benefit for single-agent anti&ndash
epidermal growth factor receptor (egfr) therapy compared with combination therapy with irinotecan in KRAS wildtype (wt) metastatic colorectal cancer (mcrc) patients in the third-line treatment set
epidermal growth factor receptor (egfr) therapy compared with combination therapy with irinotecan in KRAS wildtype (wt) metastatic colorectal cancer (mcrc) patients in the third-line treatment set
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d2e49e21e64c203556b0a2128ff110d
https://europepmc.org/articles/PMC3851344/
https://europepmc.org/articles/PMC3851344/
Publikováno v:
Southern medical journal. 93(9)
A 52-year-old man with retroperitoneal nodal, lung, and liver metastases from choriocarcinoma received chemotherapy with etoposide, cisplatin, and bleomycin. Within 48 hours of starting treatment, he had hypotension, hypoxemia, and anuria. Laboratory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eebfe6f77f2e9cc5af25ea4fea534b60
https://pubmed.ncbi.nlm.nih.gov/11005356
https://pubmed.ncbi.nlm.nih.gov/11005356
Autor:
W, John, J, Picus, C D, Blanke, J W, Clark, L N, Schulman, E K, Rowinsky, D E, Thornton, P J, Loehrer
Publikováno v:
Cancer. 88(8)
The aim of this study was to confirm the activity and assess the safety profile of multitargeted antifolate (MTA) for patients with metastatic colorectal adenocarcinoma.Forty-six patients were enrolled in the study, 35 with colon and 11 with rectal c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::787bec5a0433e203d98f4e3210d19859
https://pubmed.ncbi.nlm.nih.gov/10760756
https://pubmed.ncbi.nlm.nih.gov/10760756
Autor:
M L, Rothenberg, C D, Blanke
Publikováno v:
Seminars in oncology. 26(6)
Over the past 10 years, a number of topoisomerase I inhibitors have entered into clinical trials and several of these have been evaluated in phase II and III studies to determine their activity in patients with advanced colorectal cancer. The most ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f86f30b6fc87368c365bca8eff7d4204
https://pubmed.ncbi.nlm.nih.gov/10606256
https://pubmed.ncbi.nlm.nih.gov/10606256
Publikováno v:
Oncology (Williston Park, N.Y.). 13(10 Suppl 5)
Fluorinated pyrimidines have long been used as radiosensitizers in combined-modality therapy for solid tumors. Nonetheless, the most commonly used drug, 5-fluorouracil (5-FU), is inconvenient to administer, particularly when given by continuous intra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c2f92290db38154595870249ea6fd0dc
https://pubmed.ncbi.nlm.nih.gov/10550826
https://pubmed.ncbi.nlm.nih.gov/10550826
Autor:
C D, Blanke, H, Choy, M, Teng, R D, Beauchamp, S, Leach, J, Roberts, K, Washington, D H, Johnson
Publikováno v:
Seminars in radiation oncology. 9(2 Suppl 1)
Esophageal cancer is a major cause of morbidity and mortality worldwide. Although patients often present with apparently resectable disease, systemic spread frequently occurs before the development of symptoms and detection of tumor. The use of combi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2a786e7dd23f912ddd1df165dc28846f
https://pubmed.ncbi.nlm.nih.gov/10210539
https://pubmed.ncbi.nlm.nih.gov/10210539
Publikováno v:
Seminars in oncology. 24(5 Suppl 18)
Unresectable metastatic colorectal cancer remains a significant cause of morbidity and mortality in both the United States and Europe. To date, no chemotherapeutic regimen for this disease has demonstrated a definitive survival advantage compared wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5ffcd30b61de33015ed77eacdeb6993e
https://pubmed.ncbi.nlm.nih.gov/9420022
https://pubmed.ncbi.nlm.nih.gov/9420022
Nursing care strategies for the management of side effects in patients treated for colorectal cancer
Publikováno v:
Seminars in oncology. 24(5 Suppl 18)
Oncology nurses play a critical role in the detection and management of adverse effects resulting from the toxicity of colorectal cancer (CRC) treatment regimens. Standard chemotherapy for CRC involves combination 5-fluorouracil plus leucovorin, a re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::162b62fd302dac2278e964f9fc8f6ae0
https://pubmed.ncbi.nlm.nih.gov/9420023
https://pubmed.ncbi.nlm.nih.gov/9420023
Autor:
C D, Blanke, D H, Johnson
Publikováno v:
Seminars in thoracic and cardiovascular surgery. 9(1)
Small cell lung cancer is an extremely virulent disease that tends to present at an advanced stage and may secrete multiple hormones and neural markers. In addition to the usual symptoms of advanced lung cancer, it may also present with a paraneoplas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::723ba988448bc1498d2521b1045c2960
https://pubmed.ncbi.nlm.nih.gov/9109230
https://pubmed.ncbi.nlm.nih.gov/9109230